$BMY
Análise IAGerado em May 11, 2026
AI Score
Hold$BMY
Bristol-Myers Squibb
$BMYNYSEHealthcareLarge-Cap
Bristol-Myers Squibb discovers, develops, and delivers innovative medicines for serious diseases including cancer, cardiovascular, and immunology.
Market Cap
$100.0B
Revenue (TTM)
$45.0B
+3.0%
Net Income (TTM)
$8.0B
-5.0%
EPS (TTM)
$3.85
P/E Ratio
12.0
Dividend Yield
4.5%
52-Week Range
$40-$58
Beta
0.52
Dimension Scores
Fundamental
68Technical
60Sentiment
64Risk / Reward
72Momentum
54Financial Health
Profitability
73moderate
Growth
57moderate
Liquidity
80strong
Solvency
70strong
Efficiency
66strong
Valuation, technical analysis, investment thesis, risk assessment and more for $BMY
Free · No credit card required
Aviso: Análise gerada por IA apenas para fins educacionais. Não constitui aconselhamento financeiro. Sempre consulte um consultor financeiro qualificado.